The role of BPTF in melanoma progression and in response to BRAF-targeted therapy.

Dar, Altaf A; Nosrati, Mehdi; Bezrookove, Vladimir; de Semir, David; Majid, Shahana; Thummala, Suresh; Sun, Vera; Tong, Schuyler; Leong, Stanley P L; Minor, David; Billings, Paul R; Soroceanu, Liliana; Debs, Robert; Miller, James R; Sagebiel, Richard W; Kashani-Sabet, Mohammed

Dar, Altaf A; Nosrati, Mehdi; Bezrookove, Vladimir; de Semir, David; Majid, Shahana; Thummala, Suresh; Sun, Vera; Tong, Schuyler; Leong, Stanley P L; Minor, David; Billings, Paul R; Soroceanu, Liliana; Debs, Robert; Miller, James R; Sagebiel, Richard W; Kashani-Sabet, Mohammed.

Afiliación

Dar AA; Center for Melanoma Research and Treatment (AAD, MN, VB, DdS, ST, VS, ST, SPLL, DM, JRMIII, RWS, MKS), California Pacific Medical Center Research Institute, San Francisco, CA (AAD, MN, VB, DdS, ST, VS, ST, SPLL, DM, LS, RD, JRMIII, RWS, MKS); Department of Urology, Veterans Affairs Medical Center an
Nosrati M; Center for Melanoma Research and Treatment (AAD, MN, VB, DdS, ST, VS, ST, SPLL, DM, JRMIII, RWS, MKS), California Pacific Medical Center Research Institute, San Francisco, CA (AAD, MN, VB, DdS, ST, VS, ST, SPLL, DM, LS, RD, JRMIII, RWS, MKS); Department of Urology, Veterans Affairs Medical Center an
Bezrookove V; Center for Melanoma Research and Treatment (AAD, MN, VB, DdS, ST, VS, ST, SPLL, DM, JRMIII, RWS, MKS), California Pacific Medical Center Research Institute, San Francisco, CA (AAD, MN, VB, DdS, ST, VS, ST, SPLL, DM, LS, RD, JRMIII, RWS, MKS); Department of Urology, Veterans Affairs Medical Center an
de Semir D; Center for Melanoma Research and Treatment (AAD, MN, VB, DdS, ST, VS, ST, SPLL, DM, JRMIII, RWS, MKS), California Pacific Medical Center Research Institute, San Francisco, CA (AAD, MN, VB, DdS, ST, VS, ST, SPLL, DM, LS, RD, JRMIII, RWS, MKS); Department of Urology, Veterans Affairs Medical Center an
Majid S; Center for Melanoma Research and Treatment (AAD, MN, VB, DdS, ST, VS, ST, SPLL, DM, JRMIII, RWS, MKS), California Pacific Medical Center Research Institute, San Francisco, CA (AAD, MN, VB, DdS, ST, VS, ST, SPLL, DM, LS, RD, JRMIII, RWS, MKS); Department of Urology, Veterans Affairs Medical Center an
Thummala S; Center for Melanoma Research and Treatment (AAD, MN, VB, DdS, ST, VS, ST, SPLL, DM, JRMIII, RWS, MKS), California Pacific Medical Center Research Institute, San Francisco, CA (AAD, MN, VB, DdS, ST, VS, ST, SPLL, DM, LS, RD, JRMIII, RWS, MKS); Department of Urology, Veterans Affairs Medical Center an
Sun V; Center for Melanoma Research and Treatment (AAD, MN, VB, DdS, ST, VS, ST, SPLL, DM, JRMIII, RWS, MKS), California Pacific Medical Center Research Institute, San Francisco, CA (AAD, MN, VB, DdS, ST, VS, ST, SPLL, DM, LS, RD, JRMIII, RWS, MKS); Department of Urology, Veterans Affairs Medical Center an
Tong S; Center for Melanoma Research and Treatment (AAD, MN, VB, DdS, ST, VS, ST, SPLL, DM, JRMIII, RWS, MKS), California Pacific Medical Center Research Institute, San Francisco, CA (AAD, MN, VB, DdS, ST, VS, ST, SPLL, DM, LS, RD, JRMIII, RWS, MKS); Department of Urology, Veterans Affairs Medical Center an
Leong SP; Center for Melanoma Research and Treatment (AAD, MN, VB, DdS, ST, VS, ST, SPLL, DM, JRMIII, RWS, MKS), California Pacific Medical Center Research Institute, San Francisco, CA (AAD, MN, VB, DdS, ST, VS, ST, SPLL, DM, LS, RD, JRMIII, RWS, MKS); Department of Urology, Veterans Affairs Medical Center an
Minor D; Center for Melanoma Research and Treatment (AAD, MN, VB, DdS, ST, VS, ST, SPLL, DM, JRMIII, RWS, MKS), California Pacific Medical Center Research Institute, San Francisco, CA (AAD, MN, VB, DdS, ST, VS, ST, SPLL, DM, LS, RD, JRMIII, RWS, MKS); Department of Urology, Veterans Affairs Medical Center an
Billings PR; Center for Melanoma Research and Treatment (AAD, MN, VB, DdS, ST, VS, ST, SPLL, DM, JRMIII, RWS, MKS), California Pacific Medical Center Research Institute, San Francisco, CA (AAD, MN, VB, DdS, ST, VS, ST, SPLL, DM, LS, RD, JRMIII, RWS, MKS); Department of Urology, Veterans Affairs Medical Center an
Soroceanu L; Center for Melanoma Research and Treatment (AAD, MN, VB, DdS, ST, VS, ST, SPLL, DM, JRMIII, RWS, MKS), California Pacific Medical Center Research Institute, San Francisco, CA (AAD, MN, VB, DdS, ST, VS, ST, SPLL, DM, LS, RD, JRMIII, RWS, MKS); Department of Urology, Veterans Affairs Medical Center an
Debs R; Center for Melanoma Research and Treatment (AAD, MN, VB, DdS, ST, VS, ST, SPLL, DM, JRMIII, RWS, MKS), California Pacific Medical Center Research Institute, San Francisco, CA (AAD, MN, VB, DdS, ST, VS, ST, SPLL, DM, LS, RD, JRMIII, RWS, MKS); Department of Urology, Veterans Affairs Medical Center an
Miller JR; Center for Melanoma Research and Treatment (AAD, MN, VB, DdS, ST, VS, ST, SPLL, DM, JRMIII, RWS, MKS), California Pacific Medical Center Research Institute, San Francisco, CA (AAD, MN, VB, DdS, ST, VS, ST, SPLL, DM, LS, RD, JRMIII, RWS, MKS); Department of Urology, Veterans Affairs Medical Center an
Sagebiel RW; Center for Melanoma Research and Treatment (AAD, MN, VB, DdS, ST, VS, ST, SPLL, DM, JRMIII, RWS, MKS), California Pacific Medical Center Research Institute, San Francisco, CA (AAD, MN, VB, DdS, ST, VS, ST, SPLL, DM, LS, RD, JRMIII, RWS, MKS); Department of Urology, Veterans Affairs Medical Center an
Kashani-Sabet M; Center for Melanoma Research and Treatment (AAD, MN, VB, DdS, ST, VS, ST, SPLL, DM, JRMIII, RWS, MKS), California Pacific Medical Center Research Institute, San Francisco, CA (AAD, MN, VB, DdS, ST, VS, ST, SPLL, DM, LS, RD, JRMIII, RWS, MKS); Department of Urology, Veterans Affairs Medical Center an

J Natl Cancer Inst ; 107(5)2015 Feb 23.

Article en En | MEDLINE | ID: mdl-25713167

Asunto(s)

Antígenos Nucleares/metabolismo; Antineoplásicos/farmacología; Biomarcadores de Tumor/metabolismo; Imidazoles/farmacología; Indoles/farmacología; Melanoma/tratamiento farmacológico; Melanoma/metabolismo; Terapia Molecular Dirigida; Proteínas del Tejido Nervioso/metabolismo; Oximas/farmacología; Proteínas Proto-Oncogénicas B-raf/genética; Neoplasias Cutáneas/tratamiento farmacológico; Neoplasias Cutáneas/metabolismo; Sulfonamidas/farmacología; Factores de Transcripción/metabolismo; Animales; Progresión de la Enfermedad; Femenino; Dosificación de Gen; Regulación Neoplásica de la Expresión Génica; Immunoblotting; Inmunohistoquímica; Hibridación Fluorescente in Situ; Melanoma/genética; Ratones; Ratones Endogámicos C57BL; Ratones Desnudos; Terapia Molecular Dirigida/métodos; Mutación/efectos de los fármacos; Reacción en Cadena en Tiempo Real de la Polimerasa; Neoplasias Cutáneas/genética; Vemurafenib; Ensayos Antitumor por Modelo de Xenoinjerto

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Oximas / Neoplasias Cutáneas / Sulfonamidas / Factores de Transcripción / Biomarcadores de Tumor / Antígenos Nucleares / Proteínas Proto-Oncogénicas B-raf / Terapia Molecular Dirigida / Imidazoles / Indoles Tipo de estudio: Prognostic_studies Límite: Animals Idioma: En Revista: J Natl Cancer Inst Año: 2015 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google